CFO Anna Shlimak said higher cannabis flower sales in Israel, Canada and Germany, as well as increased Canadian cannabis extract sales, drove revenue growth. Despite geopolitical and regulatory challenges in Israel, Gorenstein said Cronos remains committed to the market. Germany growth and Netherlands acquisition remain in focusOutside Israel, Cronos’ international net revenue increased 88% year over year, led by demand in Germany. About Cronos Group (NASDAQ:CRON)Cronos Group Inc is a Canadian cannabinoid company dedicated to the cultivation, production and distribution of cannabis and cannabidiol (CBD) products for both medical and adult-use markets. The company’s branded portfolio includes Peace Naturals, which focuses on pharmaceutical-grade medical cannabis; Spinach, a line of adult-use cannabis oils and tinctures; and Cove, a range of wellness-oriented CBD offerings.